ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/08/10 | 1,730 | 1,749 | 1,697 | 1,722 | -9 | -0.5% | 1,464,700 |
| 2023/08/09 | 1,734 | 1,745 | 1,696 | 1,731 | +9 | +0.5% | 1,564,400 |
| 2023/08/08 | 1,780 | 1,791 | 1,712 | 1,722 | -58 | -3.3% | 2,664,800 |
| 2023/08/07 | 1,755 | 1,783 | 1,668 | 1,780 | +27 | +1.5% | 3,994,500 |
| 2023/08/04 | 1,758 | 1,773 | 1,741 | 1,753 | -8 | -0.5% | 1,545,700 |
| 2023/08/03 | 1,780 | 1,834 | 1,739 | 1,761 | -48 | -2.7% | 3,070,800 |
| 2023/08/02 | 1,845 | 1,853 | 1,790 | 1,809 | -37 | -2% | 2,380,800 |
| 2023/08/01 | 1,820 | 1,877 | 1,808 | 1,846 | +32 | +1.8% | 4,237,400 |
| 2023/07/31 | 1,859 | 1,886 | 1,814 | 1,814 | -14 | -0.8% | 5,125,400 |
| 2023/07/28 | 1,723 | 1,838 | 1,721 | 1,828 | +53 | +3% | 7,058,800 |
| 2023/07/27 | 1,862 | 1,865 | 1,753 | 1,775 | -119 | -6.3% | 10,504,700 |
| 2023/07/26 | 1,794 | 1,896 | 1,794 | 1,894 | +100 | +5.6% | 14,301,800 |
| 2023/07/25 | 1,771 | 1,839 | 1,707 | 1,794 | +24 | +1.4% | 17,009,600 |
| 2023/07/24 | 1,575 | 1,798 | 1,542 | 1,770 | +197 | +12.5% | 22,283,900 |
| 2023/07/21 | 1,508 | 1,660 | 1,491 | 1,573 | +157 | +11.1% | 22,828,900 |
| 2023/07/20 | 1,449 | 1,456 | 1,416 | 1,416 | -67 | -4.5% | 2,486,600 |
| 2023/07/19 | 1,444 | 1,503 | 1,444 | 1,483 | +53 | +3.7% | 2,879,700 |
| 2023/07/18 | 1,415 | 1,430 | 1,392 | 1,430 | +10 | +0.7% | 1,987,900 |
| 2023/07/14 | 1,436 | 1,453 | 1,404 | 1,420 | -27 | -1.9% | 1,773,900 |
| 2023/07/13 | 1,429 | 1,447 | 1,371 | 1,447 | +33 | +2.3% | 3,858,600 |
| 2023/07/12 | 1,525 | 1,536 | 1,400 | 1,414 | -112 | -7.3% | 5,008,900 |
| 2023/07/11 | 1,530 | 1,565 | 1,520 | 1,526 | +10 | +0.7% | 2,530,900 |
| 2023/07/10 | 1,491 | 1,550 | 1,491 | 1,516 | +10 | +0.7% | 3,331,500 |
| 2023/07/07 | 1,537 | 1,566 | 1,486 | 1,506 | -49 | -3.2% | 4,742,700 |
| 2023/07/06 | 1,568 | 1,624 | 1,554 | 1,555 | -26 | -1.6% | 5,366,400 |
| 2023/07/05 | 1,568 | 1,607 | 1,541 | 1,581 | +2 | +0.1% | 5,520,500 |
| 2023/07/04 | 1,524 | 1,627 | 1,515 | 1,579 | +68 | +4.5% | 13,322,400 |
| 2023/07/03 | 1,543 | 1,546 | 1,483 | 1,511 | +11 | +0.7% | 10,827,500 |
| 2023/06/30 | 1,453 | 1,526 | 1,424 | 1,500 | +59 | +4.1% | 18,344,000 |
| 2023/06/29 | 1,600 | 1,610 | 1,390 | 1,441 | -519 | -26.5% | 52,341,400 |
| 2023/06/28 | 1,960 | 1,960 | 1,960 | 1,960 | -500 | -20.3% | 156,300 |
| 2023/06/27 | 2,460 | 2,460 | 2,460 | 2,460 | -700 | -22.2% | 158,400 |
| 2023/06/26 | 2,957 | 3,175 | 2,948 | 3,160 | +188 | +6.3% | 1,553,500 |
| 2023/06/23 | 3,020 | 3,030 | 2,964 | 2,972 | -33 | -1.1% | 811,800 |
| 2023/06/22 | 2,950 | 3,015 | 2,931 | 3,005 | +47 | +1.6% | 883,800 |
| 2023/06/21 | 2,907 | 3,040 | 2,886 | 2,958 | +101 | +3.5% | 1,905,900 |
| 2023/06/20 | 2,839 | 2,873 | 2,775 | 2,857 | -31 | -1.1% | 1,312,300 |
| 2023/06/19 | 2,896 | 2,911 | 2,831 | 2,888 | +2 | +0.1% | 1,022,600 |
| 2023/06/16 | 2,818 | 2,904 | 2,816 | 2,886 | +46 | +1.6% | 1,144,900 |
| 2023/06/15 | 2,971 | 2,983 | 2,802 | 2,840 | -158 | -5.3% | 1,925,000 |
| 2023/06/14 | 2,970 | 3,025 | 2,946 | 2,998 | +30 | +1% | 762,400 |
| 2023/06/13 | 3,025 | 3,070 | 2,952 | 2,968 | -37 | -1.2% | 1,052,500 |
| 2023/06/12 | 2,947 | 3,025 | 2,929 | 3,005 | +45 | +1.5% | 718,900 |
| 2023/06/09 | 2,998 | 3,030 | 2,952 | 2,960 | -15 | -0.5% | 636,500 |
| 2023/06/08 | 2,954 | 3,010 | 2,931 | 2,975 | -40 | -1.3% | 990,700 |
| 2023/06/07 | 3,055 | 3,075 | 2,999 | 3,015 | -55 | -1.8% | 724,300 |
| 2023/06/06 | 3,085 | 3,095 | 3,035 | 3,070 | +10 | +0.3% | 598,000 |
| 2023/06/05 | 3,070 | 3,080 | 3,005 | 3,060 | +35 | +1.2% | 678,500 |
| 2023/06/02 | 3,090 | 3,115 | 3,005 | 3,025 | -90 | -2.9% | 956,200 |
| 2023/06/01 | 3,105 | 3,160 | 3,090 | 3,115 | -20 | -0.6% | 470,100 |
451～
500
件表示中 / 5111件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 92,000円 | +20.3% | - | 0.00% | 163.12倍 | 1.22倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 148,400円 | -2.4% | -52.3% | 3.84% | 17.76倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 220,000円 | +4.1% | -3.1% | 2.64% | 19.16倍 | 1.67倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ＪＣＲファーマ | 55,400円 | +14.3% | - | 3.61% | 22.50倍 | 1.44倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| あすかＨＤ | 233,000円 | +16.9% | +33.2% | 2.36% | 12.71倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム
